Title | Type | SJR | H index | Total Docs. (2000) | Total Docs. (3years) | Total Refs. (2000) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2000) | %Female (2000) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
507 | Alcoholism: Clinical and Experimental Research | journal | 0.958 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
506 | Anti-Cancer Drug Design | journal | 0.910 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
505 | Chemical Speciation and Bioavailability | journal | 0.284 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
504 | Clin-Alert | journal | 0.100 Q4 | 0 | 0 | 47 | 0 | 0 | 47 | 0.00 | 0.00 | 0.00 | |
503 | Immunopharmacology | journal | 0.554 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
502 | International Journal of Immunopharmacology | journal | 0.350 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
501 | Japanese Journal of Pharmacology | journal | 0.519 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
500 | Japanese Journal of Psychopharmacology | journal | 0.178 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
499 | Journal of Lipid Mediators and Cell Signalling | journal | 0.456 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
498 | Journal of Venomous Animals and Toxins | journal | 0.113 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
497 | Modern Trends in Pharmacopsychiatry | journal | 0.518 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
496 | Perspectives in Drug Discovery and Design | journal | 0.834 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
495 | Pharmaceutica Acta Helvetiae | journal | 0.206 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
494 | Pharmaceutical Science and Technology Today | journal | 0.385 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
493 | Pharmaceutical Sciences | journal | 0.200 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
492 | Pharmacie Hospitaliere Francaise | journal | 0.103 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
491 | Pharmacy and Pharmacology Communications | journal | 0.260 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
490 | Toxic Substance Mechanisms | journal | 0.151 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
489 | Toxicology Methods | journal | 0.316 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
488 | British journal of clinical practice. Supplement | journal | 0.121 Q4 | 1 | 0 | 1 | 0 | 0 | 1 | 0.00 | 0.00 | 0.00 | |
487 | Giornale di Neuropsicofarmacologia | journal | 0.100 Q4 | 1 | 18 | 64 | 353 | 0 | 64 | 0.00 | 19.61 | 55.81 | |
486 | IDMA Bulletin | journal | 0.101 Q4 | 1 | 0 | 47 | 0 | 0 | 14 | 0.00 | 0.00 | 0.00 | |
485 | In Vitro Toxicology: Journal of Molecular and Cellular Toxicology | journal | 0.114 Q4 | 1 | 0 | 3 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
484 | Schweizer Apothekerzeitung | journal | 0.101 Q4 | 1 | 0 | 17 | 0 | 0 | 15 | 0.00 | 0.00 | 0.00 | |
483 | Therapie und Erfolg | journal | 0.101 Q4 | 1 | 0 | 42 | 0 | 0 | 31 | 0.00 | 0.00 | 0.00 | |
482 | Therapiewoche | journal | 1 | 37 | 0 | 81 | 0 | 0 | 0.00 | 2.19 | 40.00 | ||
481 | Therapiewoche Schweiz | journal | 0.100 Q4 | 1 | 15 | 135 | 0 | 1 | 107 | 0.00 | 0.00 | 66.67 | |
480 | Annual Report of Shionogi Research Laboratory | journal | 0.235 Q3 | 2 | 2 | 6 | 143 | 2 | 6 | 0.25 | 71.50 | 33.33 | |
479 | Ciencia Pharmaceutica | journal | 0.155 Q3 | 2 | 0 | 23 | 0 | 5 | 22 | 0.00 | 0.00 | 0.00 | |
478 | Gyogyszereszet | journal | 0.100 Q4 | 2 | 6 | 69 | 171 | 4 | 69 | 0.05 | 28.50 | 0.00 | |
477 | Pharmaceutical Visions | journal | 0.100 Q4 | 2 | 40 | 143 | 42 | 4 | 48 | 0.04 | 1.05 | 66.67 | |
476 | Psychopharmakotherapie, Supplement | journal | 0.119 Q4 | 2 | 0 | 9 | 0 | 0 | 5 | 0.00 | 0.00 | 0.00 | |
475 | American Druggist | journal | 0.102 Q4 | 3 | 0 | 150 | 0 | 3 | 120 | 0.03 | 0.00 | 0.00 | |
474 | Circular Farmaceutica | journal | 0.100 Q4 | 3 | 47 | 135 | 243 | 2 | 114 | 0.01 | 5.17 | 75.00 | |
473 | Farmaceutisch Tijdschrift voor Belgie | journal | 0.100 Q4 | 3 | 13 | 53 | 368 | 0 | 52 | 0.00 | 28.31 | 33.33 | |
472 | Klinische Pharmakologie Aktuell | journal | 0.102 Q4 | 3 | 12 | 48 | 41 | 3 | 36 | 0.08 | 3.42 | 40.00 | |
471 | Lyon Pharmaceutique | journal | 0.102 Q4 | 3 | 0 | 76 | 0 | 4 | 72 | 0.00 | 0.00 | 0.00 | |
470 | Acta Poloniae Toxicologica | journal | 0.111 Q4 | 4 | 27 | 26 | 808 | 1 | 26 | 0.04 | 29.93 | 62.86 | |
469 | Drugs Made in Germany | journal | 0.100 Q4 | 4 | 8 | 58 | 90 | 2 | 50 | 0.03 | 11.25 | 25.00 | |
468 | Indian Journal of Indigenous Medicines | journal | 0.101 Q4 | 4 | 0 | 25 | 0 | 3 | 24 | 0.00 | 0.00 | 0.00 | |
467 | International Pharmacy Journal | journal | 0.101 Q4 | 4 | 0 | 169 | 0 | 3 | 145 | 0.01 | 0.00 | 0.00 | |
466 | Phytomedica | journal | 0.102 Q4 | 4 | 14 | 13 | 196 | 0 | 12 | 0.00 | 14.00 | 12.50 | |
465 | Acta Technologiae et Legis Medicamenti | journal | 0.102 Q4 | 5 | 0 | 40 | 0 | 3 | 40 | 0.12 | 0.00 | 0.00 | |
464 | Antimicrobics and Infectious Diseases Newsletter | journal | 0.130 Q4 | 5 | 18 | 44 | 624 | 8 | 42 | 0.15 | 34.67 | 29.17 | |
463 | Current Opinion in Anti-inflammatory and Immunomodulatory Investigational Drugs | journal | 5 | 35 | 0 | 2174 | 0 | 0 | 0.00 | 62.11 | 23.53 | ||
462 | Current Therapeutics | journal | 0.110 Q4 | 5 | 95 | 155 | 893 | 7 | 155 | 0.03 | 9.40 | 42.86 | |
461 | EOS Rivista di Immunologia ed Immunofarmacologia | journal | 0.126 Q4 | 5 | 19 | 59 | 1135 | 16 | 57 | 0.25 | 59.74 | 35.56 | |
460 | Epitheorese Klinikes Farmakologias kai Farmakokinetikes | journal | 0.101 Q4 | 5 | 14 | 36 | 506 | 1 | 36 | 0.05 | 36.14 | 50.00 | |
459 | Farmacevtski Vestnik (discontinued) | journal | 0.168 Q3 | 5 | 42 | 272 | 898 | 11 | 272 | 0.03 | 21.38 | 38.98 | |
458 | Journal of Pharmacoepidemiology | journal | 0.107 Q4 | 5 | 4 | 12 | 123 | 1 | 8 | 0.00 | 30.75 | 23.08 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®